Diabetes Meds Flashcards

1
Q

HbA1c Tx targets for newly diagnosed

A

48 mmol/mol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

HbA1x Tx target for diabetics who moved beyond metformin

A

53 mmol/mol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

a weight neutral biguanide that increases insulin sensitivity and decreases liver glucose production

A

metformin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

a feature of metformin that makes it possible to reverse diarrhea & abdominal pain by lowering the dose

A

dose dependent med

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

does metformin typically cause hypoglycaemia

A

no

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

a very dangerous side effect of metformin

A

lactic acidosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

a thiazoidinedione that has the same effects as metformin

A

pioglitazone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

notable side effects of pioglitazone (5)

A
  • weight gain
  • fluid retention
  • anaemia
  • HF
  • bladder cancer
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

does pioglitazone usually cause hypoglycaemia

A

no

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

the most common sulfonylurea that stimulates insulin production from pancreas

A

gliclazide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

weight effects of gliclazide

A

wight gain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

can gliclazide lead to hypoglycaemia

A

yes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

when does gliclazide increase the risk of CVD/MI

A

when used as monotherapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

GI hormones released by GI tract in response to large meals

A

incretins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

main incretin is … which can be inhibited by …

A
  • GLP1 (glucagon-like peptide-1)

- DPP-4 (dipeptidyl peptidase-4)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

most common DPP-4 inhibitor thus increasing GLP1 activity

A

sitagliptin

17
Q

notable side effects of DPP-4 inhibitors

A
  • GI tract upset
  • UPTI symptoms
  • pancreatitis
18
Q

GLP-1 mimetics that can be used in combination with other diabetes drugs

A
  • exenatide

- liraglutide

19
Q

SGLT-2 inhibitors end with the suffix

A

gliflozin

20
Q

why is there a risk of glucoseuria, UTI, weight loss when taking empagliflozin

A

– glucose reabsorption in proximal tubules –> ++ glucose in urine

21
Q

limb amputation is commonly associated with which SGLT-2 inhibitor

A

canogliflozin

22
Q

1st line in peripheral neuropathy

A

tricyclic anti-depressants

23
Q

1st line diabetic neuropathy (3)

A

Pregabalin
Duloxetine
Gabapentin

24
Q

when should exenatide be avoided and why

A

pregnancy; class c teratogen